Skip to main content
Erschienen in: Social Justice Research 2/2019

17.12.2018

Explicit Cost-Effectiveness Thresholds in Health Care: A Kaleidoscope

verfasst von: Jeroen Luyten, Yvonne Denier

Erschienen in: Social Justice Research | Ausgabe 2/2019

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Although the principles of cost-effectiveness analysis have been adopted by health systems worldwide, a large majority of countries remain reluctant to specify explicit threshold values for cost-effectiveness. Nonetheless, by aiming to benchmark what counts as a reasonable ‘price’ for health gains, the threshold value is a linchpin in the framework of health technology assessment, albeit also a controversial one. The desirability of thresholds depends largely on three claims: their intention to make resource allocation more efficient, their aspiration to make decision-making more transparent and their objective to make healthcare systems more sustainable. In this paper, we draw from various disciplines such as health economics but also psychology, anthropology, sociology, political sciences and ethics to discuss the many facets of these three values, related to the threshold debate. We discuss issues of allocative efficiency, fair decision-making, realpolitik, taboos, institutional justice and the rule of rescue. Based upon these considerations, which together substantiate the precautionary principle, we conclude that the case against thresholds is stronger than the case in favor and that most countries are right to be reluctant to use explicit threshold values.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Fußnoten
1
With the latter, we mean official, publicly available thresholds of what constitutes a cost-effective healthcare program (e.g., £30,000/QALY).
 
2
The first is that of communal sharing, which divides social life into two groups (members and non-members) that both have different rights and obligations (a binary dichotomy). A typical example is the distinction between family members and non-family members, friends and non-friends, between citizens and non-citizens. Membership means an equal right to the benefits of the group, non-membership leads to no entitlements. The second sphere is that of authority ranking, based on one’s status and location in a social hierarchy (a lexical ordinal ranking of people). A typical example is the superior status of a person like the president or the king, having more authority than others because of their higher place in the hierarchy. The third sphere is that of equality matching where we settle scores between equal partners (allowing to measure). This is the sphere of equals, colleagues or friends inviting one another over for dinner, for example. Within this sphere, a ‘tit-for-tat’ reciprocity between equals dominates (e.g., after a certain amount of time, we’re expected to return a dinner invitation). The fourth sphere is that of market pricing, where a single metric (like money, for instance) makes valuation and comparison of a large number of entities possible (allowing ratios and all kinds of calculations and weighing of costs and benefits) (Fiske & Tetlock, 1997).
 
3
An interesting illustration can be found in the ‘Danner Commission’ experiment (Shoemaker & Tetlock, 2012), in which participants were informed about a fictionalized public health program and its recommended reforms in the light of efficient use of public resources. If the reforms were followed, the program could save 200 lives, at a cost of $100 million. If the program continued at the previous year’s budget of $200 million, 400 lives could be saved. In the experiment, the Commission recommended not to continue and instead, to redirect the saving of $100 million to other important public uses. This is a clear example of a policy choice that requires explicit valuation of human life. The researchers investigated people’s response to different explanation strategies. For two groups, the Commission offered a smokescreen strategy that took either a utilitarian form (‘After weighing relevant costs and benefits, the Commission concludes that this is the right thing to do’) or moralistic form (‘Based on its analysis, the Commission concludes that morally this is the right thing to do’). For a third group, the decision grounds were presented transparently (‘The cost of saving the additional 200 lives (at $500,000 per life) is too high given other important priorities’). In the first two groups (where the trade-offs remained implicit), around 72% supported the recommendation. In the third group (with the explicit trade-off), approval went down to 35%.
 
Literatur
Zurück zum Zitat Afzali, H. H. A., Karnon, J., & Sculpher, M. (2016). Should the lambda (λ) remain silent? PharmacoEconomics, 34, 323–329.CrossRef Afzali, H. H. A., Karnon, J., & Sculpher, M. (2016). Should the lambda (λ) remain silent? PharmacoEconomics, 34, 323–329.CrossRef
Zurück zum Zitat Bertram, M. Y., Lauer, J. A., De Joncheere, K., Edejer, T., Hutubessy, R., Kieny, M. P., et al. (2016). Cost-effectiveness thresholds: Pros and cons. Bulletin of the World Health Organization, 94(12), 925–930.CrossRefPubMedPubMedCentral Bertram, M. Y., Lauer, J. A., De Joncheere, K., Edejer, T., Hutubessy, R., Kieny, M. P., et al. (2016). Cost-effectiveness thresholds: Pros and cons. Bulletin of the World Health Organization, 94(12), 925–930.CrossRefPubMedPubMedCentral
Zurück zum Zitat Birch, S., & Gafni, A. (2006). Information created to evade reality (ICER): Things we should not look to for answers. Pharmacoeconomics, 11, 1121–1131.CrossRef Birch, S., & Gafni, A. (2006). Information created to evade reality (ICER): Things we should not look to for answers. Pharmacoeconomics, 11, 1121–1131.CrossRef
Zurück zum Zitat Birch, S., & Gafni, A. (2015). On the margins of health economics: A response to ‘resolving NICE’s nasty dilemma. Health Economics, Policy & Law, 10, 183–193.CrossRef Birch, S., & Gafni, A. (2015). On the margins of health economics: A response to ‘resolving NICE’s nasty dilemma. Health Economics, Policy & Law, 10, 183–193.CrossRef
Zurück zum Zitat Buchanan, A., Brock, D., Daniels, N., & Wikler, D. (2000). From chance to choice: Genetics and justice. Cambridge: Cambridge University Press.CrossRef Buchanan, A., Brock, D., Daniels, N., & Wikler, D. (2000). From chance to choice: Genetics and justice. Cambridge: Cambridge University Press.CrossRef
Zurück zum Zitat Burggraeve, R. (1995). The ethical meaning of money in the thought of Emmanuel Levinas. Ethical Perspectives, 2(2), 85–90.CrossRef Burggraeve, R. (1995). The ethical meaning of money in the thought of Emmanuel Levinas. Ethical Perspectives, 2(2), 85–90.CrossRef
Zurück zum Zitat Burggraeve, R. (2015). Ethics as crisis: Levinas’ contribution to a humane society. In R. Serpytyte (Ed.), Emmanuel Levinas: A radical thinker in the time of crisis (pp. 9–26). Vilnius: Vilnius University. Burggraeve, R. (2015). Ethics as crisis: Levinas’ contribution to a humane society. In R. Serpytyte (Ed.), Emmanuel Levinas: A radical thinker in the time of crisis (pp. 9–26). Vilnius: Vilnius University.
Zurück zum Zitat Callahan, D. (1991b). The oregon initiative: Ethics and priority setting. Health Matrix, 1(2), 157–170.PubMed Callahan, D. (1991b). The oregon initiative: Ethics and priority setting. Health Matrix, 1(2), 157–170.PubMed
Zurück zum Zitat Claxton, K., Martin, S., Soares, M., Rice, N., Spackman, E., Hinde, S., et al. (2015). Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold. Health Technol Assess, 19(14), 1–503. v–vi.CrossRefPubMedPubMedCentral Claxton, K., Martin, S., Soares, M., Rice, N., Spackman, E., Hinde, S., et al. (2015). Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold. Health Technol Assess, 19(14), 1–503. v–vi.CrossRefPubMedPubMedCentral
Zurück zum Zitat Clement, F. M., Harris, A., Li, J. J., Yong, K., Lee, K. M., & Manns, B. J. (2009). Using effectiveness and cost-effectiveness to make drug coverage decisions: A comparison of Britain, Australia, and Canada. JAMA, 302(13), 1437–1443.CrossRefPubMed Clement, F. M., Harris, A., Li, J. J., Yong, K., Lee, K. M., & Manns, B. J. (2009). Using effectiveness and cost-effectiveness to make drug coverage decisions: A comparison of Britain, Australia, and Canada. JAMA, 302(13), 1437–1443.CrossRefPubMed
Zurück zum Zitat Cohen, I. G., Daniels, N., & Eyal, N. (2015). Identified versus statistical lives. An interdisciplinary perspective. Oxford: Oxford University Press.CrossRef Cohen, I. G., Daniels, N., & Eyal, N. (2015). Identified versus statistical lives. An interdisciplinary perspective. Oxford: Oxford University Press.CrossRef
Zurück zum Zitat Cookson, R., McDaid, D., & Maynard, A. (2001). Wrong SIGN, NICE mess: Is national guidance distorting allocation of resources? BMJ, 323, 5–743.CrossRef Cookson, R., McDaid, D., & Maynard, A. (2001). Wrong SIGN, NICE mess: Is national guidance distorting allocation of resources? BMJ, 323, 5–743.CrossRef
Zurück zum Zitat Creadon, M. (1997). The ocean denied. Time, 149, 3. Creadon, M. (1997). The ocean denied. Time, 149, 3.
Zurück zum Zitat Daniels, N. (1996). Justice and justification. Reflective equilibrium in theory and practice. Cambridge: Cambridge University Press.CrossRef Daniels, N. (1996). Justice and justification. Reflective equilibrium in theory and practice. Cambridge: Cambridge University Press.CrossRef
Zurück zum Zitat Daniels, N. (1999). Enabling democratic deliberation: How managed care organisations ought to make decisions about coverage for new technologies. In S. Macedo (Ed.), Deliberative politics: Essays on democracy and disagreement (pp. 198–210). New York: Oxford University Press. Daniels, N. (1999). Enabling democratic deliberation: How managed care organisations ought to make decisions about coverage for new technologies. In S. Macedo (Ed.), Deliberative politics: Essays on democracy and disagreement (pp. 198–210). New York: Oxford University Press.
Zurück zum Zitat Daniels, N. (2001). Justice, health, and healthcare. American Journal of Bioethics, 1(2), 2–16.CrossRef Daniels, N. (2001). Justice, health, and healthcare. American Journal of Bioethics, 1(2), 2–16.CrossRef
Zurück zum Zitat Daniels, N. (2008). Just health: Meeting health needs fairly. New York: Cambridge University Press. Daniels, N. (2008). Just health: Meeting health needs fairly. New York: Cambridge University Press.
Zurück zum Zitat Daniels, N., & Sabin, J. E. (1997). Limits to health care: Fair procedures, democratic deliberation, and the legitimacy problem for insurers. Philosophy and Public Affairs, 26, 303–350.CrossRefPubMed Daniels, N., & Sabin, J. E. (1997). Limits to health care: Fair procedures, democratic deliberation, and the legitimacy problem for insurers. Philosophy and Public Affairs, 26, 303–350.CrossRefPubMed
Zurück zum Zitat Daniels, N., & Sabin, J. (1998). The ethics of accountability and the reform of managed care organisations. Health Affairs, 17(5), 50–69.CrossRefPubMed Daniels, N., & Sabin, J. (1998). The ethics of accountability and the reform of managed care organisations. Health Affairs, 17(5), 50–69.CrossRefPubMed
Zurück zum Zitat Daniels, N., & Sabin, J. E. (2002). Setting limits fairly: Can we learn to share medical resources?. Oxford: Oxford University Press.CrossRef Daniels, N., & Sabin, J. E. (2002). Setting limits fairly: Can we learn to share medical resources?. Oxford: Oxford University Press.CrossRef
Zurück zum Zitat Danzon, P. M., et al. (2018). Objectives, budgets, thresholds, and opportunity costs-a health economics approach: An ISPOR special task force report [4]. Value Health, 21(2), 140–145.CrossRefPubMed Danzon, P. M., et al. (2018). Objectives, budgets, thresholds, and opportunity costs-a health economics approach: An ISPOR special task force report [4]. Value Health, 21(2), 140–145.CrossRefPubMed
Zurück zum Zitat Descartes (1994) Oeuvres et Lettres, Paris: Gallimard. (Ed. and Trans. G. Heffernan). Discourse on the method, Notre Dame: University of Notre Dame Press. Descartes (1994) Oeuvres et Lettres, Paris: Gallimard. (Ed. and Trans. G. Heffernan). Discourse on the method, Notre Dame: University of Notre Dame Press.
Zurück zum Zitat Drummond, M., Sculpher, M. J., Torrance, G., O’Brien, G., & Stoddard, G. (2005). Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press. Drummond, M., Sculpher, M. J., Torrance, G., O’Brien, G., & Stoddard, G. (2005). Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press.
Zurück zum Zitat Durkheim, E. (1925). Moral education. A study in the theory and application of the sociology of education (Ed. E.K. Wilson, E.K. Wilson & H. Schnurer, Transl.) (1973). New York: Free Press. Durkheim, E. (1925). Moral education. A study in the theory and application of the sociology of education (Ed. E.K. Wilson, E.K. Wilson & H. Schnurer, Transl.) (1973). New York: Free Press.
Zurück zum Zitat Dworkin, R. (1993). Justice in the distribution of health care, repr. In M. Clayton; A. Williams (eds.), The ideal of equality, 2002 (pp. 203–222). Basingstoke: Palgrave Macmillan. Dworkin, R. (1993). Justice in the distribution of health care, repr. In M. Clayton; A. Williams (eds.), The ideal of equality, 2002 (pp. 203–222). Basingstoke: Palgrave Macmillan.
Zurück zum Zitat Dworkin, R. (1994). Justice and the high cost of health, repr. in id., Sovereign Virtue. In The theory and practice of equality, 2000 (pp. 307–319). Cambridge: Harvard University Press. Dworkin, R. (1994). Justice and the high cost of health, repr. in id., Sovereign Virtue. In The theory and practice of equality, 2000 (pp. 307–319). Cambridge: Harvard University Press.
Zurück zum Zitat Eichler, H. G., Kong, S. X., Gerth, W. C., Mavros, P., & Jonsson, B. (2004). Use of cost-effectiveness analysis in health-care resource allocation decision-making: How are cost-effectiveness thresholds expected to emerge? Value Health, 7(5), 518–528.CrossRefPubMed Eichler, H. G., Kong, S. X., Gerth, W. C., Mavros, P., & Jonsson, B. (2004). Use of cost-effectiveness analysis in health-care resource allocation decision-making: How are cost-effectiveness thresholds expected to emerge? Value Health, 7(5), 518–528.CrossRefPubMed
Zurück zum Zitat Fiske, A., & Tetlock, P. (1997). ‘Taboo trade-offs: Reactions to transactions that transgress the spheres of justice. Political Psychology, 18(2), 255–297.CrossRef Fiske, A., & Tetlock, P. (1997). ‘Taboo trade-offs: Reactions to transactions that transgress the spheres of justice. Political Psychology, 18(2), 255–297.CrossRef
Zurück zum Zitat Fleurbaey, M., & Schokkaert, E. (2012). Equity in health and health care. In M. V. Pauly, T. G. McGuire, & P. P. Barros (Eds.), Handbook of health economics (Vol. 2, pp. 1003–1092). New York: Elsevier. Fleurbaey, M., & Schokkaert, E. (2012). Equity in health and health care. In M. V. Pauly, T. G. McGuire, & P. P. Barros (Eds.), Handbook of health economics (Vol. 2, pp. 1003–1092). New York: Elsevier.
Zurück zum Zitat Gafni, A., & Birch, S. (2006). Incremental cost-effectiveness ratios (ICERs): The silence of the lambda. Social Science & Medicine, 62, 2091–2100.CrossRef Gafni, A., & Birch, S. (2006). Incremental cost-effectiveness ratios (ICERs): The silence of the lambda. Social Science & Medicine, 62, 2091–2100.CrossRef
Zurück zum Zitat George, B., Harris, A., & Mitchell, A. (2001). Cost-effectiveness analysis and the consistency of decision making: Evidence from pharmaceutical reimbursement in australia (1991 to 1996). Pharmacoeconomics, 19(11), 1103–1109.CrossRefPubMed George, B., Harris, A., & Mitchell, A. (2001). Cost-effectiveness analysis and the consistency of decision making: Evidence from pharmaceutical reimbursement in australia (1991 to 1996). Pharmacoeconomics, 19(11), 1103–1109.CrossRefPubMed
Zurück zum Zitat Gold, M., Siegel, J., Russell, L., & Weinstein, M. C. (1994). Cost-effectiveness in health and medicine. New York: Oxford University Press. Gold, M., Siegel, J., Russell, L., & Weinstein, M. C. (1994). Cost-effectiveness in health and medicine. New York: Oxford University Press.
Zurück zum Zitat Hadorn, D. C. (1991). The oregon priority-setting exercise: Quality of life and public policy. Hastings Center Report, 21(3), 11–16.CrossRef Hadorn, D. C. (1991). The oregon priority-setting exercise: Quality of life and public policy. Hastings Center Report, 21(3), 11–16.CrossRef
Zurück zum Zitat Ham, C. (1997). Priority setting in health care: Learning from international experience. Health Policy, 42(1), 49–66.CrossRefPubMed Ham, C. (1997). Priority setting in health care: Learning from international experience. Health Policy, 42(1), 49–66.CrossRefPubMed
Zurück zum Zitat Hausman, D. M. (2006). Valuing health. Philosophy & Public Affairs, 34(3), 246–274.CrossRef Hausman, D. M. (2006). Valuing health. Philosophy & Public Affairs, 34(3), 246–274.CrossRef
Zurück zum Zitat Hausman, D. (2015). Valuing health. New York: Oxford University Press. Hausman, D. (2015). Valuing health. New York: Oxford University Press.
Zurück zum Zitat Jecker, N. S. (2013). Justice between age groups: An objection to the prudential lifespan approach. AJOB, 13(8), 3–15.PubMed Jecker, N. S. (2013). Justice between age groups: An objection to the prudential lifespan approach. AJOB, 13(8), 3–15.PubMed
Zurück zum Zitat Jonsen, A. R. (1986). Bentham in a box: Technology assessment and health care allocation. Law, Medicine, and Health Care, 14, 172–174.CrossRef Jonsen, A. R. (1986). Bentham in a box: Technology assessment and health care allocation. Law, Medicine, and Health Care, 14, 172–174.CrossRef
Zurück zum Zitat Levinas, E. (1969). Totality and infinity. An essay in exteriority. (A. Lingis, Transl.). Pittsburgh: Duquesne University Press. Levinas, E. (1969). Totality and infinity. An essay in exteriority. (A. Lingis, Transl.). Pittsburgh: Duquesne University Press.
Zurück zum Zitat Levinas, E. (1981). Otherwise than being and beyond essence. (A. Lingis, Transl.). Pittsburgh: Duquesne University Press. Levinas, E. (1981). Otherwise than being and beyond essence. (A. Lingis, Transl.). Pittsburgh: Duquesne University Press.
Zurück zum Zitat Levinas, E. (1987). Time and the other. (R.A. Cohen, Transl.). Pittsburgh: Duquesne University Press. Levinas, E. (1987). Time and the other. (R.A. Cohen, Transl.). Pittsburgh: Duquesne University Press.
Zurück zum Zitat Levinas, E. (1990). Nine talmudic readings (A. Aronowicz, Transl.). Bloomington: Indiana University Press. Levinas, E. (1990). Nine talmudic readings (A. Aronowicz, Transl.). Bloomington: Indiana University Press.
Zurück zum Zitat Levinas, E. (2006). Thinking-of-the-other. London: Continuum. Levinas, E. (2006). Thinking-of-the-other. London: Continuum.
Zurück zum Zitat Marseille, E., Larson, B., Kazi, D. S., Kahn, J. G., & Rosen, S. (2015). Thresholds for the cost-effectiveness of interventions: Alternative approaches. Bull World Health Organ, 93(2), 118–124.CrossRefPubMed Marseille, E., Larson, B., Kazi, D. S., Kahn, J. G., & Rosen, S. (2015). Thresholds for the cost-effectiveness of interventions: Alternative approaches. Bull World Health Organ, 93(2), 118–124.CrossRefPubMed
Zurück zum Zitat McCabe, C., Claxton, K., & Culyer, A. J. (2008). The NICE cost-effectiveness threshold: What it is and what that means. Pharmacoeconomics, 26(9), 733–744.CrossRefPubMed McCabe, C., Claxton, K., & Culyer, A. J. (2008). The NICE cost-effectiveness threshold: What it is and what that means. Pharmacoeconomics, 26(9), 733–744.CrossRefPubMed
Zurück zum Zitat McGraw, P. A., Davis, D. F., Scott, S. E., & Tetlock, P. E. (2016). The price of not putting a price on love. Judgement and Decision Making, 11(1), 40–47. McGraw, P. A., Davis, D. F., Scott, S. E., & Tetlock, P. E. (2016). The price of not putting a price on love. Judgement and Decision Making, 11(1), 40–47.
Zurück zum Zitat McGraw, P. A., & Tetlock, P. E. (2005). Taboo trade-offs, relational framing, and the acceptability of exchanges. Journal of Consumer Psychology, 15(1), 2–15.CrossRef McGraw, P. A., & Tetlock, P. E. (2005). Taboo trade-offs, relational framing, and the acceptability of exchanges. Journal of Consumer Psychology, 15(1), 2–15.CrossRef
Zurück zum Zitat Mckie, J., & Richardson, J. (2003). The rule of rescue. Social Science & Medicine, 56, 2407–2419.CrossRef Mckie, J., & Richardson, J. (2003). The rule of rescue. Social Science & Medicine, 56, 2407–2419.CrossRef
Zurück zum Zitat Nussbaum, M. C. (2000). The costs of tragedy: Some moral limits of cost-benefit analysis. Journal of Legal Studies, 29, 1005–1036.CrossRef Nussbaum, M. C. (2000). The costs of tragedy: Some moral limits of cost-benefit analysis. Journal of Legal Studies, 29, 1005–1036.CrossRef
Zurück zum Zitat Pearson, S. D., & Rawlins, M. D. (2005). Quality, innovation, and value for money: NICE and the British National Health Service. JAMA, 294(20), 2618–2622.CrossRefPubMed Pearson, S. D., & Rawlins, M. D. (2005). Quality, innovation, and value for money: NICE and the British National Health Service. JAMA, 294(20), 2618–2622.CrossRefPubMed
Zurück zum Zitat Sabik, L. M., & Lie, R. K. (2008). Priority setting in health care: Lessons from the experiences of eight countries. International Journal for Equity in Health, 7, 4.CrossRefPubMedPubMedCentral Sabik, L. M., & Lie, R. K. (2008). Priority setting in health care: Lessons from the experiences of eight countries. International Journal for Equity in Health, 7, 4.CrossRefPubMedPubMedCentral
Zurück zum Zitat Schildmann, J., & Vollmann, J. (2017). Personalized medicine: Conceptual, ethical and empirical challenges. In T. Schramme & S. Edwards (Eds.), Handbook of the philosophy of medicine. Dordrecht: Springer. Schildmann, J., & Vollmann, J. (2017). Personalized medicine: Conceptual, ethical and empirical challenges. In T. Schramme & S. Edwards (Eds.), Handbook of the philosophy of medicine. Dordrecht: Springer.
Zurück zum Zitat Schoemaker, P. J. H., & Tetlock, P. E. (2012). Taboo scenarios: How to think about the unthinkable. California Management Review, 54(2), 5–24.CrossRef Schoemaker, P. J. H., & Tetlock, P. E. (2012). Taboo scenarios: How to think about the unthinkable. California Management Review, 54(2), 5–24.CrossRef
Zurück zum Zitat Schokkaert, E. (2009). Willingness to pay and solidarity. In M. Wynants (Ed.), In sickness and in health. The future of medicine (pp. 99–111). Brussel: VUB Press. Schokkaert, E. (2009). Willingness to pay and solidarity. In M. Wynants (Ed.), In sickness and in health. The future of medicine (pp. 99–111). Brussel: VUB Press.
Zurück zum Zitat Schokkaert, E. (2011). Philosophers and taboo trade-offs in health care. In A. Gosseries & Y. Vanderborght (Eds.), Arguing about justice. Essays for Philippe Van Parijs (pp. 303–309). Louvain-la-Neuve: Presses universitaires de Louvain. Schokkaert, E. (2011). Philosophers and taboo trade-offs in health care. In A. Gosseries & Y. Vanderborght (Eds.), Arguing about justice. Essays for Philippe Van Parijs (pp. 303–309). Louvain-la-Neuve: Presses universitaires de Louvain.
Zurück zum Zitat Segall, S. (2009). Health, luck and justice. New Jersey: Princeton University Press.CrossRef Segall, S. (2009). Health, luck and justice. New Jersey: Princeton University Press.CrossRef
Zurück zum Zitat Sendi, P., Gafni, A., & Birch, S. (2002). Opportunity costs and uncertainty in the economic evaluation of healthcare interventions. Health Economics, 11, 23–31.CrossRefPubMed Sendi, P., Gafni, A., & Birch, S. (2002). Opportunity costs and uncertainty in the economic evaluation of healthcare interventions. Health Economics, 11, 23–31.CrossRefPubMed
Zurück zum Zitat Steel, D. (2014). Philosophy and the precautionary principle. Cambridge: Cambridge University Press.CrossRef Steel, D. (2014). Philosophy and the precautionary principle. Cambridge: Cambridge University Press.CrossRef
Zurück zum Zitat Tetlock, P. (2003). Thinking the unthinkable: Sacred values and taboo cognitions. Trends in Cognitive Sciences, 7(7), 320–324.CrossRefPubMed Tetlock, P. (2003). Thinking the unthinkable: Sacred values and taboo cognitions. Trends in Cognitive Sciences, 7(7), 320–324.CrossRefPubMed
Zurück zum Zitat Tetlock, P. E., Peterson, R. S., & Lerner, J. S. (1996). Revising the value pluralism model: Incorporating social content and context postulates. In C. Seligman, J. Olson, & M. Zanna (Eds.), Values. Eight annual Ontario symposium on personality and social psychology (pp. 25–51). Hillsdale: Erlbaum. Tetlock, P. E., Peterson, R. S., & Lerner, J. S. (1996). Revising the value pluralism model: Incorporating social content and context postulates. In C. Seligman, J. Olson, & M. Zanna (Eds.), Values. Eight annual Ontario symposium on personality and social psychology (pp. 25–51). Hillsdale: Erlbaum.
Zurück zum Zitat Tetlock, P., et al. (2000). The psychology of the unthinkable: Taboo trade-offs, forbidden base rates and heretical counterfacts. Journal of Personality and Social Psychology, 78, 853–870.CrossRefPubMed Tetlock, P., et al. (2000). The psychology of the unthinkable: Taboo trade-offs, forbidden base rates and heretical counterfacts. Journal of Personality and Social Psychology, 78, 853–870.CrossRefPubMed
Zurück zum Zitat Thokala, P., Ochalek, J., Leech, A. A., & Tong, T. (2018). Cost-effectiveness thresholds: The past, the present and the future. Pharmacoeconomics, 36(5), 509–522.CrossRefPubMed Thokala, P., Ochalek, J., Leech, A. A., & Tong, T. (2018). Cost-effectiveness thresholds: The past, the present and the future. Pharmacoeconomics, 36(5), 509–522.CrossRefPubMed
Zurück zum Zitat Vollmann, J., Sandow, V., Wäscher, S., & Schildman, J. (2015). The ethics of personalised medicine: Critical perspectives. London: Routledge. Vollmann, J., Sandow, V., Wäscher, S., & Schildman, J. (2015). The ethics of personalised medicine: Critical perspectives. London: Routledge.
Zurück zum Zitat Weinstein, M., & Zeckhauser, R. (1973). Critical ratios and efficient allocation. Journal of Public Economics, 2(2), 147–157.CrossRef Weinstein, M., & Zeckhauser, R. (1973). Critical ratios and efficient allocation. Journal of Public Economics, 2(2), 147–157.CrossRef
Zurück zum Zitat Williams, A. H., & Cookson, R. A. (2006). Equity-efficiency trade-offs in health technology assessment. International Journal of Technology Assessment in Health Care, 22(1), 1–9.CrossRefPubMed Williams, A. H., & Cookson, R. A. (2006). Equity-efficiency trade-offs in health technology assessment. International Journal of Technology Assessment in Health Care, 22(1), 1–9.CrossRefPubMed
Zurück zum Zitat Woods, B., et al. (2016). Country-level cost-effectiveness thresholds: Initial estimates and the need for further research. Value Health, 19(8), 929–935.CrossRefPubMedPubMedCentral Woods, B., et al. (2016). Country-level cost-effectiveness thresholds: Initial estimates and the need for further research. Value Health, 19(8), 929–935.CrossRefPubMedPubMedCentral
Metadaten
Titel
Explicit Cost-Effectiveness Thresholds in Health Care: A Kaleidoscope
verfasst von
Jeroen Luyten
Yvonne Denier
Publikationsdatum
17.12.2018
Verlag
Springer US
Erschienen in
Social Justice Research / Ausgabe 2/2019
Print ISSN: 0885-7466
Elektronische ISSN: 1573-6725
DOI
https://doi.org/10.1007/s11211-018-0322-9

Weitere Artikel der Ausgabe 2/2019

Social Justice Research 2/2019 Zur Ausgabe